{
    "organizations": [],
    "uuid": "b5704f540357dc1566cd919bfd7b38c7c95888f2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fibrocell-science-says-submitted-i/brief-fibrocell-science-says-submitted-ind-application-for-fcx-013-to-treat-type-of-skin-disorder-idUSFWN1PV0WK",
    "ord_in_thread": 0,
    "title": "BRIEF-Fibrocell Science Says Submitted IND Application For FCX-013 To Treat Type Of Skin Disorder",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 5 (Reuters) - Fibrocell Science Inc:\n* FIBROCELL SCIENCE SAYS SUBMITTED INVESTIGATIONAL NEW DRUG APPLICATION FOR FCX-013 FOR TREATMENT OF MODERATE TO SEVERE LOCALIZED SCLERODERMAâ€‹ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-05T21:29:00.000+02:00",
    "crawled": "2018-02-07T00:04:41.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "fibrocell",
        "science",
        "inc",
        "fibrocell",
        "science",
        "say",
        "submitted",
        "investigational",
        "new",
        "drug",
        "application",
        "treatment",
        "moderate",
        "severe",
        "localized",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}